The relation of uric acid to brain atrophy and cognition: The rotterdam scan study

Neuroepidemiology

Volumn 41, Issue 1, 2013, Pages 29-34

  Verhaaren, Benjamin F J ^a   Vernooij, Meike W ^a   Dehghan, Abbas ^a   Vrooman, Henri A ^a   De Boer, Renske ^a   Hofman, Albert ^a   Witteman, Jacqueline C M ^a   Niessen, Wiro J ^a,b   Breteler, Monique M B ^a,c   Van Der Lugt, Aad ^a   Ikram, M Arfan ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

^c GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

Brain atrophy; Cognition; Hyperuricemia; Magnetic resonance imaging; Uric acid; Vascular brain disease

Indexed keywords

URIC ACID;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN ATROPHY; BRAIN TISSUE; COGNITION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; HYPERURICEMIA; LABORATORY AUTOMATION; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; SCORING SYSTEM; SEX RATIO; URIC ACID BLOOD LEVEL; VALIDATION STUDY; WHITE MATTER ATROPHY; WHITE MATTER LESION;

AGED; ATROPHY; BRAIN; COGNITION; COGNITION DISORDERS; FEMALE; HUMANS; HYPERURICEMIA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NETHERLANDS; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS;

EID: 84875638346     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000346606     Document Type: Article

References (34)

1. Schneider JA, Bennett DA: Where vascular meets neurodegenerative disease. Stroke 2010; 41:S144-S146.
2. Knopman DS, Roberts R: Vascular risk fac-tors: Imaging and neuropathologic correlates. J Alzheimers Dis 2010; 20:699-709.
3. Ikram MA, Vrooman HA, Vernooij MW, den Heijer T, Hofman A, Niessen WJ, van der Lugt A, Koudstaal PJ, Breteler MM: Brain tis-sue volumes in relation to cognitive function and risk of dementia. Neurobiol Aging 2010; 31:378-386.
4. Feig DI, Kang DH, Johnson RJ: Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 1811-1821.
5. Bos MJ, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM: Uric acid is a risk factor for myocardial infarction and stroke: the Rotter-dam study. Stroke 2006; 37:1503-1507. (Pubitemid 44305733)
6. Hozawa A, Folsom AR, Ibrahim H, Javier Ni-eto F, Rosamond WD, Shahar E: Serum uric acid and risk of ischemic stroke: the ARIC study. Atherosclerosis 2006; 187:401-407. (Pubitemid 43963022)
7. Vannorsdall TD, Jinnah HA, Gordon B, Kraut M, Schretlen DJ: Cerebral ischemia me-diates the effect of serum uric acid on cogni-tive function. Stroke 2008; 39:3418-3420.
8. Schretlen DJ, Inscore AB, Vannorsdall TD, Kraut M, Pearlson GD, Gordon B, Jinnah HA: Serum uric acid and brain ischemia in normal elderly adults. Neurology 2007; 69:1418-1423. (Pubitemid 47511463)
9. Heo SH, Lee SH: High levels of serum uric acid are associated with silent brain infarc-tion. J Neurol Sci 2010; 297:6-10.
10. Debette S, Seshadri S, Beiser A, Au R, Himali JJ, Palumbo C, Wolf PA, Decarli C: Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 2011; 77:461-468.
11. Hofman A, van Duijn CM, Franco OH, Ikram MA, Janssen HL, Klaver CC, Kuipers EJ, Ni-jsten TE, Stricker BH, Tiemeier H, Uitterlin-den AG, Vernooij MW, Witteman JC: The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol 2011; 26:657-686.
12. Ikram MA, van der Lugt A, Niessen WJ, Kres-tin GP, Koudstaal PJ, Hofman A, Breteler MM, Vernooij MW: The Rotterdam Scan Study: design and update up to 2012. Eur J Epidemiol 2011; 26:811-824.
13. Trivedi RC, Rebar L, Desai K, Stong LJ: New ultraviolet (340 nm) method for assay of uric acid in serum or plasma. Clin Chem 1978; 24: 562-566. (Pubitemid 8316535)
14. Vrooman HA, Cocosco CA, van der Lijn F, Stokking R, Ikram MA, Vernooij MW, Breteler MM, Niessen WJ: Multi-spectral brain tissue segmentation using automatically trained k-nearest-neighbor classification. Neuroimage 2007; 37: 71-81. (Pubitemid 47068998)
15. de Boer R, Vrooman HA, van der Lijn F, Ver-nooij MW, Ikram MA, van der Lugt A, et al: White matter lesion extension to automatic brain tissue segmentation on MRI. Neuroim-age 2009; 45:1151-1161.
16. Kruit MC, Launer LJ, Ferrari MD, van Bu-chem MA: Infarcts in the posterior circula-tion territory in migraine. The population-based MRI CAMERA study. Brain 2005; 128: 2068-2077.
17. Bleecker ML, Bolla-Wilson K, Agnew J, Mey-ers DA: Age-related sex differences in verbal memory. J Clin Psychol 1988; 44:403-411.
18. Golden CJ: Identification of brain disorders by the Stroop color and word test. J Clin Psy-chol 1976; 32:654-658.
19. Lezak MD, Howieson DB, Loring DW: Neu-ropsychological assessment. New York, Ox-ford University Press, 2004.
20. Welsh KA, Butters N, Mohs RC, Beekly D, Edland S, Fillenbaum G, Heyman A: The Consortium to Establish a Registry for Al-zheimer's Disease (CERAD). Part V. A nor-mative study of the neuropsychological bat-tery. Neurology 1994; 44:609-614. (Pubitemid 24129983)
21. Ikram MA, Vernooij MW, Hofman A, Nies-sen WJ, van der Lugt A, Breteler MM: Kidney function is related to cerebral small vessel dis-ease. Stroke 2008; 39:55-61.
22. Verhaaren BF, Vernooij MW, Koudstaal PJ, Uitterlinden AG, Duijn CM, Hofman A, Bre-teler MM, Ikram MA: Alzheimer's disease genes and cognition in the nondemented gen-eral population. Biol 2013;73:429-434.
23. Euser SM, Schram MT, Hofman A, Westen-dorp RG, Breteler MM: Measuring cognitive function with age: the influence of selection by health and survival. Epidemiology 2008; 19:440-447. (Pubitemid 351543522)
24. Euser SM, Hofman A, Westendorp RG, Bre-teler MM: Serum uric acid and cognitive func-tion and dementia. Brain 2009; 132:377-382.
25. Hall AP, Barry PE, Dawber TR, McNamara PM: Epidemiology of gout and hyperurice-mia. A long-term population study. Am J Med 1967; 42:27-37.
26. Chang HY, Tung CW, Lee PH, Lei CC, Hsu YC, Chang HH, Yang HF, Lu LC, Jong MC, Chen CY, Fang KY, Chao YS, Shih YH, Lin CL: Hyperuricemia as an independent risk factor of chronic kidney disease in middle-aged and elderly population. Am J Med Sci 2010; 339:509-515.
27. Ogino K, Hisatome I, Saitoh M, Miyamoto J, Ishiko R, Hasegawa J, Kotake H, Mashiba H: Clinical significance of hypouricemia in hos-pitalized patients. J Med 1991; 22:76-82.
28. Salat DH, Lee SY, van der Kouwe AJ, Greve DN, Fischl B, Rosas HD: Age-associated al-terations in cortical gray and white matter sig-nal intensity and gray to white matter con-trast. Neuroimage 2009; 48:21-28.
29. Schretlen DJ, Inscore AB, Jinnah HA, Rao V, Gordon B, Pearlson GD: Serum uric acid and cognitive function in community-dwelling old-er adults. Neuropsychology 2007; 21: 136-140. (Pubitemid 46066213)
30. Afsar B, Elsurer R, Covic A, Johnson RJ, Kan-bay M: Relationship between uric acid and subtle cognitive dysfunction in chronic kid-ney disease. Am J Nephrol 2011; 34:49-54.
31. Scuteri A, Nilsson PM, Tzourio C, Redon J, Laurent S: Microvascular brain damage with aging and hypertension: pathophysiological consideration and clinical implications. J Hy-pertens 2011; 29:1469-1477.
32. Alvarez-Lario B, Macarron-Vicente J: Uric acid and evolution. Rheumatology (Oxford) 2010; 49:2010-2015.
33. Wirdefeldt K, Adami HO, Cole P, Trichopou-los D, Mandel J: Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol 2011; 26(suppl1):S1-S58.
34. Brundel M, de Bresser J, van Dillen JJ, Kappelle LJ, Biessels GJ: Cerebral microinfarcts: a sys-tematic review of neuropathological studies. J Cereb Blood Flow Metab 2012; 32: 425-436.